Chemistry |
Structure-Fxn relationships that were relied upon in the past have become less important |
| |
Instead, receptor-fxn relationships and functional assays are more clinically relevant |
✽ Classification According to Potency ✽ |
Low Potency |
Chlorpromazine |
| |
Thioridazine |
Medium Potency |
Loxapine |
| |
Perphenazine |
High Potency |
Haloperidol |
| |
Droperidol |
| |
Fluphenazine |
| |
Pimozide |
✽ MOA ✽ |
Block dopamine D2 receptors |
D2 receptor binding affinity (but not D1) strongly correlates with clinical potency of typical antipsychotic agents |
Blockade of postsynaptic D2 receptors |
⇨ Reduction of dopaminergic neurotransmission |
D2 receptor blockade in ALL dopaminergic pathways |
⇨ beneficial in the mesolimbic pathway |
| |
⇨ alleviates positive sx of SZ |
| |
⇨ It doesn't do really anything for the negative or cognitive sx |
| |
Side Effects: |
| |
• D2 receptor blockade in nigrostriatal pathway ⇨ extrapyramidal sx (EPS) |
| |
• D2 receptor blockade in the tuberoinfundibular pathway ⇨ increased prolactin release from the anterior pituitary |
Blocks other receptors: |
5-HT2A blockade |
Contributes to antipsychotic effects |
Other receptor blockade |
Numerous additional side effect |
✽ SIDE EFFECTS ✽ |
EPS |
Various movement disorders associated with antipsychotic therapy (occurs mostly with 1st gen) |
| |
Occurs due to D2 receptor blockade in the nigrostriatal pathway |
| |
• Akathisia: uncontrollable motor restlessness |
| |
• Dystonias: muscular spasms of the neck, eyes, and tongue |
| |
• Drug-Induced Parkinson's Syndrome: Resembles Parkinson's Syndrome |
| |
• Tardive Dyskinesia (TD): occurs after months or years of tx; may become irreversible; repetitive, involuntary, purposeless movements (typically facial muscles are involved); mechanism: up-regulation and supersensitivity of D2 receptors (that can become permanent) |
Hyperprolactinemia |
D2 receptor blockade in the tuberoinfundibular pathway causes increased plasma prolactin levels (Hyperprolactinemia) |
| |
Manifested as: Amenorrhea-galactorrhea in women, gynecomastia in men, Infertility in both men and women |
ADRs caused by Blockade of Non-Dopamine Receptors |
1st generation antipsychotic drugs also block 5-HT-2, alpha 1 adrenergic, muscarinic, and histamine H-1 receptors ⇨ More Side Effects |
Blockade of H1 Receptors |
Sedation |
Blockade of alpha 1 adrenergic receptors |
Orthostatic hypotension (could result in falls and injuries) |
Blockade of muscarinic receptors |
dry mouth, urinary retention, blurred vision, tachycardia, constipation, toxic-confusional state |
Blockade of both H1 and 5-HT-2A receptors |
Weight gain |
ADDITIONAL SIDE EFFECTS |
Typical antipsychotic agents affect hypothalamic function |
impaired ability to regulate body temperature |
| |
Hypo or Hyperthermia may result, depending on the ambient temperature |
Thioridazine |
Cardiac toxicity: reflected in prolongation of QTc interval and abnormal configuration of ST segment and T wave (correlates to increased risk of ventricular arrhythmias) |
| |
Retinal Tox: (pigmentary retinopathy): decreased vision and "browining" of vision |
Neuroleptic Malignant Syndrome (NMS) |
Rare, but life-threatening reaction to antipsychotic drugs |
| |
Symptoms: extreme muscle rigidity (lead pipe), hyperreflecia, fever, unstable BP, tachycardia, sweating, rapid changes in mental status, confusion, and coma |
| |
Lab: myoglobinemia and metabolic acidosis |
Created By
Metadata
Comments
Good job for the effort, but need to be refined and detailed.
Great job
Add a Comment
Related Cheat Sheets
More Cheat Sheets by kfisher17